RAPP Rapport Therapeutics, Inc.: institutional ownership and insider trading
166 funds reported holding $2.18B of Rapport Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net sold $51.4M, with 25 new positions and 12 funds selling out; over the last 12 months insiders bought $1.66M and sold $47.2M on the open market.
Famous investors holding RAPP
- D. E. Shaw (D. E. Shaw & Co.): $8.95M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $6.46M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $3.44M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.02M, 0.0% of the portfolio
Largest institutional holders of RAPP
- FMR LLC — $299M
- TRV GP V, LLC — $262M
- ARCH Venture Management, LLC — $155M
- Capital International Investors — $122M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $121M
- BlackRock, Inc. (BLK) — $113M
- Cormorant Asset Management, LP — $111M
- Sofinnova Investments, Inc. — $79.4M
- JOHNSON & JOHNSON (JNJ) — $74.4M
- Polar Capital Holdings Plc — $67.0M
Recent RAPP insider trades
- Oct 23, 2026: Sanchez Ramiro bought 3,600 shares ($98.5K)
- Oct 22, 2026: Maraganore John bought 9,411 shares ($249K)
- Oct 22, 2026: Paul Steven M bought 35,714 shares ($974K)
- Oct 22, 2026: Young Wendy B. bought 3,789 shares ($100.0K)
5%+ owners
- Third Rock Ventures V, L.P.: 13.1% (Schedule 13G/A, filed Aug 14, 2026)
- Capital International Investors: 6.1% (Schedule 13G/A, filed Aug 12, 2026)
- Cormorant Asset Management, LP: 5.6% (Schedule 13G/A, filed Aug 14, 2026)